ASBPW Aspire Biopharma Holdings, Inc.: institutional ownership and insider trading
34 funds reported holding $179K of Aspire Biopharma Holdings, Inc. in their latest 13F filings; in Q2 2026 funds net sold $2.09K, with 1 new positions and 3 funds selling out; over the last 12 months insiders bought $0 and sold $0 on the open market.
Famous investors holding ASBPW
- Izzy Englander (Millennium Management): $5.50K, 0.0% of the portfolio
- D. E. Shaw (D. E. Shaw & Co.): $4.10K, 0.0% of the portfolio
Largest institutional holders of ASBPW
- Saba Capital Management, L.P. — $22.9K
- ADAGE CAPITAL PARTNERS GP, L.L.C. — $21.0K
- LINDEN ADVISORS LP — $21.0K
- ARISTEIA CAPITAL, L.L.C. — $15.9K
- CLEAR STREET LLC — $14.8K
- TORONTO DOMINION BANK (TD, TDBCP) — $10.3K
- Sculptor Capital LP — $10.0K
- Clear Street Group Inc. — $6.61K
- MILLENNIUM MANAGEMENT LLC — $5.50K
- CAAS CAPITAL MANAGEMENT LP — $5.08K
Recent ASBPW insider trades
- Jun 5, 2025: Fell Donald G. bought 20,000 shares ($7.80K)
5%+ owners
- Lance Friedman: 7.9% (Schedule 13G/A, filed Aug 6, 2026)
- GARY SHIRINYAN: 7.7% (Schedule 13G, filed Aug 10, 2026)
- Rubenbauer Alois Ryan III: 5.0% (Schedule 13G, filed Jul 2, 2026)